Advertisement Press Releases Archive - Page 156 of 233 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • Hybrigenics 2010 Revenues and Cash Position

    Hybrigenics (ALHYG), a bio-pharmaceutical group with a focus on research and development of new cancer treatments and a fully-owned subsidiary specialized in protein interaction services, today announces its revenues and cash position for the year ended 31 December 2010.

  • ECLINSO Announces Partnership with XClinical

    ECLINSO AG, a leading provider of clinical information technology, consulting and business process outsourcing services, announced today that it has entered into a strategic partnership agreement with XClinical GmbH.

  • Jury Awards $52 Million in Damages to Promega

    The United States District Court for the Western District of Wisconsin, a jury awarded $52,009,941 in damages to Promega Corporation (Madison, WI) for infringing sales by Life Technologies (Carlsbad, CA).

  • More Tools for Researchers on the Promega iPhone/iPad App

    The Promega App is now available in a new format optimized for easy use on both iPhone and iPad, and it's supplemented with more tools for scientists and students. New content in version 3.0 includes a Restriction Enzyme Finder, a new Biochemical Buffers chapter, and additional instructional videos on transfection and PCR purification.

  • New Promega QuantiFluor RNA System for Sensitive, Easy Quantitation

    Promega Corporation announces the launch of QuantiFluor™ RNA System for highly sensitive, easy RNA quantitation. The QuantiFluor RNA dye enables quantitation of small amounts (as little as 100pg) of RNA in solution; a critical step in many biological applications, particularly in standard molecular biology techniques.

  • Promega Corporation Building New Facility to Support Regulated Product Manufacturing

    Promega Corporation breaks ground today for a "Current Good Manufacturing Practice" (cGMP) facility dedicated to accommodate business growth and its customers who need FDA-regulated molecular biology products. These include components such as sample preparation systems and reagents which are part of diagnostic and medical tests sold by human diagnostic test providers